These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15516858)

  • 21. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
    Exner DV; Dries DL; Waclawiw MA; Shelton B; Domanski MJ
    J Am Coll Cardiol; 1999 Mar; 33(4):916-23. PubMed ID: 10091816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure].
    Tereshchenko SN; Kositsyna IV; Dzhaiani NA; Golubev AV; Kochetov AG
    Kardiologiia; 2005; 45(6):19-22. PubMed ID: 16007029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure complicating acute myocardial infarction.
    Aronow WS
    Clin Geriatr Med; 2000 Aug; 16(3):535-48. PubMed ID: 10918646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-blockers in heart failure: recently completed and ongoing clinical trials.
    McAreavey D; Exner DV; Curtin EL; Domanski MJ
    Expert Opin Investig Drugs; 2000 Feb; 9(2):415-28. PubMed ID: 11060685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.
    Fonarow GC; Abraham WT; Cannon CP; Gheorghiade M; Sackner-Bernstein JD; Udelson JE;
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S54-9. PubMed ID: 14584479
    [No Abstract]   [Full Text] [Related]  

  • 31. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
    Munkhaugen J; Ruddox V; Halvorsen S; Dammen T; Fagerland MW; Hernæs KH; Vethe NT; Prescott E; Jensen SE; Rødevand O; Jortveit J; Bendz B; Schirmer H; Køber L; Bøtker HE; Larsen AI; Vikenes K; Steigen T; Wiseth R; Pedersen T; Edvardsen T; Otterstad JE; Atar D
    Am Heart J; 2019 Feb; 208():37-46. PubMed ID: 30530121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
    MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding role of beta-blockade in the management of chronic heart failure.
    Patterson JH; Rodgers JE
    Pharmacotherapy; 2003 Apr; 23(4):451-9. PubMed ID: 12680475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of inpatient initiation of beta-blockers.
    Ventura HO
    Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic effects on cardiac remodeling.
    Sharpe N
    Curr Heart Fail Rep; 2004; 1(1):9-13. PubMed ID: 16036019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
    Ghio S; Constantin C; Raineri C; Fontana A; Klersy C; Campana C; Tavazzi L
    Cardiovasc Ultrasound; 2003 Sep; 1():13. PubMed ID: 14596683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
    Torp-Pedersen C; Køber L; Ball S; Hall A; Brendorp B; Ottesen M; Berning J; Jensen G; Hampton J; Zilles P; Eberle S; Carlsen J
    Eur J Heart Fail; 2002 Aug; 4(4):495-9. PubMed ID: 12167390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.